NCT00477529 2019-11-22ABI-008 Trial in Patients With Hormone-refractory Prostate CancerCelgenePhase 1/2 Completed102 enrolled
NCT00928252 2017-08-14Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate CancerQueen's Medical CenterPhase 1/2 Completed25 enrolled 9 charts
NCT00286806 2010-08-24A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate CancerAscenta TherapeuticsPhase 1/2 Completed27 enrolled